BIOMAT Database Logo BIOMAT Database Logo

Scleral buckle infection with ciprofloxacin-resistant Pseudomonas aeruginosa. 1998

N A Chaudhry, and H Tabandeh, and P J Rosenfeld, and D Miller, and J Davis

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D012163 Retinal Detachment Separation of the inner layers of the retina (neural retina) from the pigment epithelium. Retinal detachment occurs more commonly in men than in women, in eyes with degenerative myopia, in aging and in aphakia. It may occur after an uncomplicated cataract extraction, but it is seen more often if vitreous humor has been lost during surgery. (Dorland, 27th ed; Newell, Ophthalmology: Principles and Concepts, 7th ed, p310-12). Retinal Pigment Epithelial Detachment,Detachment, Retinal,Detachments, Retinal,Retinal Detachments
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents

Related Publications

N A Chaudhry, and H Tabandeh, and P J Rosenfeld, and D Miller, and J Davis
Ciprofloxacin-resistant. Pseudomonas aeruginosa strain.
January 1989, Medical laboratory sciences,
N A Chaudhry, and H Tabandeh, and P J Rosenfeld, and D Miller, and J Davis
Multi-drug resistant Mycobacterium chelonae scleral buckle infection.
June 2018, American journal of ophthalmology case reports,
N A Chaudhry, and H Tabandeh, and P J Rosenfeld, and D Miller, and J Davis
Scleral buckle infection with Alcaligenes xylosoxidans.
June 2014, Indian journal of ophthalmology,
N A Chaudhry, and H Tabandeh, and P J Rosenfeld, and D Miller, and J Davis
Scleral buckle infection with Aspergillus flavus.
January 2008, Middle East African journal of ophthalmology,
N A Chaudhry, and H Tabandeh, and P J Rosenfeld, and D Miller, and J Davis
Scleral Buckle Infection With Pseudallescheria boydii.
August 2017, Ophthalmic surgery, lasers & imaging retina,
N A Chaudhry, and H Tabandeh, and P J Rosenfeld, and D Miller, and J Davis
Ciprofloxacin for respiratory tract infection with Pseudomonas aeruginosa.
December 1987, Pharmaceutisch weekblad. Scientific edition,
N A Chaudhry, and H Tabandeh, and P J Rosenfeld, and D Miller, and J Davis
MYCOBACTERIUM ABSCESSUS SCLERAL BUCKLE INFECTION.
November 2023, Retinal cases & brief reports,
N A Chaudhry, and H Tabandeh, and P J Rosenfeld, and D Miller, and J Davis
Ciprofloxacin treatment of periapical Pseudomonas aeruginosa infection.
June 1988, Endodontics & dental traumatology,
N A Chaudhry, and H Tabandeh, and P J Rosenfeld, and D Miller, and J Davis
Emergence of ciprofloxacin-resistant Pseudomonas aeruginosa after combined therapy with ciprofloxacin and amikacin.
December 1986, The Journal of antimicrobial chemotherapy,
N A Chaudhry, and H Tabandeh, and P J Rosenfeld, and D Miller, and J Davis
Ciprofloxacin therapy of respiratory tract infection with Pseudomonas aeruginosa.
October 1988, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Copied contents to your clipboard!